155 related articles for article (PubMed ID: 35785416)
1. Modulation of calcineurin signaling during development.
Tucker Edmister S; Creton R
Dev Neurobiol; 2022 Sep; 82(6):505-516. PubMed ID: 35785416
[TBL] [Abstract][Full Text] [Related]
2. A zebrafish model for calcineurin-dependent brain function.
Tucker Edmister S; Ibrahim R; Kakodkar R; Kreiling JA; Creton R
Behav Brain Res; 2022 Jan; 416():113544. PubMed ID: 34425181
[TBL] [Abstract][Full Text] [Related]
3. NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect.
Stefos GC; Soppa U; Dierssen M; Becker W
PLoS One; 2013; 8(6):e67470. PubMed ID: 23825664
[TBL] [Abstract][Full Text] [Related]
4. Perturbed Calcineurin-NFAT Signaling Is Associated with the Development of Alzheimer's Disease.
Asai M; Kinjo A; Kimura S; Mori R; Kawakubo T; Shirotani K; Yagishita S; Maruyama K; Iwata N
Biol Pharm Bull; 2016; 39(10):1646-1652. PubMed ID: 27725441
[TBL] [Abstract][Full Text] [Related]
5. Effects of embryonic cyclosporine exposures on brain development and behavior.
Clift DE; Thorn RJ; Passarelli EA; Kapoor M; LoPiccolo MK; Richendrfer HA; Colwill RM; Creton R
Behav Brain Res; 2015 Apr; 282():117-24. PubMed ID: 25591474
[TBL] [Abstract][Full Text] [Related]
6. Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles.
Tucker Edmister S; Del Rosario Hernández T; Ibrahim R; Brown CA; Gore SV; Kakodkar R; Kreiling JA; Creton R
Sci Rep; 2022 Apr; 12(1):6120. PubMed ID: 35449173
[TBL] [Abstract][Full Text] [Related]
7. Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation.
Jung MS; Park JH; Ryu YS; Choi SH; Yoon SH; Kwen MY; Oh JY; Song WJ; Chung SH
J Biol Chem; 2011 Nov; 286(46):40401-12. PubMed ID: 21965663
[TBL] [Abstract][Full Text] [Related]
8. A single extra copy of Down syndrome critical region 1-4 results in impaired hepatic glucose homeostasis.
Seo DS; Chau GC; Baek KH; Um SH
Mol Metab; 2019 Mar; 21():82-89. PubMed ID: 30583978
[TBL] [Abstract][Full Text] [Related]
9. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.
Baek KH; Zaslavsky A; Lynch RC; Britt C; Okada Y; Siarey RJ; Lensch MW; Park IH; Yoon SS; Minami T; Korenberg JR; Folkman J; Daley GQ; Aird WC; Galdzicki Z; Ryeom S
Nature; 2009 Jun; 459(7250):1126-30. PubMed ID: 19458618
[TBL] [Abstract][Full Text] [Related]
10. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways.
Fuentes JJ; Genescà L; Kingsbury TJ; Cunningham KW; Pérez-Riba M; Estivill X; de la Luna S
Hum Mol Genet; 2000 Jul; 9(11):1681-90. PubMed ID: 10861295
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin and its regulator, RCAN1, confer time-of-day changes in susceptibility of the heart to ischemia/reperfusion.
Rotter D; Grinsfelder DB; Parra V; Pedrozo Z; Singh S; Sachan N; Rothermel BA
J Mol Cell Cardiol; 2014 Sep; 74():103-11. PubMed ID: 24838101
[TBL] [Abstract][Full Text] [Related]
12. Depolarization of neural cells induces transcription of the Down syndrome critical region 1 isoform 4 via a calcineurin/nuclear factor of activated T cells-dependent pathway.
Cano E; Canellada A; Minami T; Iglesias T; Redondo JM
J Biol Chem; 2005 Aug; 280(33):29435-43. PubMed ID: 15975916
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling.
Rodrigues-Diez R; González-Guerrero C; Ocaña-Salceda C; Rodrigues-Diez RR; Egido J; Ortiz A; Ruiz-Ortega M; Ramos AM
Sci Rep; 2016 Jun; 6():27915. PubMed ID: 27295076
[TBL] [Abstract][Full Text] [Related]
14. Bidirectional Regulation of Amyloid Precursor Protein-Induced Memory Defects by Nebula/DSCR1: A Protein Upregulated in Alzheimer's Disease and Down Syndrome.
Shaw JL; Zhang S; Chang KT
J Neurosci; 2015 Aug; 35(32):11374-83. PubMed ID: 26269644
[TBL] [Abstract][Full Text] [Related]
15. The Down syndrome critical region protein RCAN1 regulates long-term potentiation and memory via inhibition of phosphatase signaling.
Hoeffer CA; Dey A; Sachan N; Wong H; Patterson RJ; Shelton JM; Richardson JA; Klann E; Rothermel BA
J Neurosci; 2007 Nov; 27(48):13161-72. PubMed ID: 18045910
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway.
Yu JJ; Zhang Y; Wang Y; Wen ZY; Liu XH; Qin J; Yang JL
Psychopharmacology (Berl); 2013 Jan; 225(2):361-72. PubMed ID: 22875481
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T-Cell Augmentation or Interleukin-17 Inhibition Prevents Calcineurin Inhibitor-Induced Hypertension in Mice.
Chiasson VL; Pakanati AR; Hernandez M; Young KJ; Bounds KR; Mitchell BM
Hypertension; 2017 Jul; 70(1):183-191. PubMed ID: 28584011
[TBL] [Abstract][Full Text] [Related]
18. Down syndrome critical region 1 enhances the proteolytic cleavage of calcineurin.
Lee JE; Jang H; Cho EJ; Youn HD
Exp Mol Med; 2009 Jul; 41(7):471-7. PubMed ID: 19322033
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the electrophoretic mobility of the linker for activation of T cells (LAT) by the calcineurin inhibitors CsA and FK506: LAT is a potential substrate for PKC and calcineurin signaling pathways.
Cho CS; Elkahwaji J; Chang Z; Scheunemann TL; Manthei ER; Hamawy MM
Cell Signal; 2003 Jan; 15(1):85-93. PubMed ID: 12401523
[TBL] [Abstract][Full Text] [Related]
20. Regulator of calcineurin 1 controls growth plasticity of adult pancreas.
Gurda GT; Crozier SJ; Ji B; Ernst SA; Logsdon CD; Rothermel BA; Williams JA
Gastroenterology; 2010 Aug; 139(2):609-19, 619.e1-6. PubMed ID: 20438729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
